TipRanks
Go Ultimate55% OFF

Vor Biopharma (VOR) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
TelitaciceptPrimary Sjogren's DiseasePhase IIIRecruitingPhase 3 Study of Telitacicept in Active Primary Sjögren's DiseaseFeb 04, 2026―
TelitaciceptSystemic Lupus ErythematosusPhase IIIWithdrawnA Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)Jun 07, 2024―
TelitaciceptGeneralized Myasthenia GravisPhase IIIRecruitingA Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Jun 07, 2024
Vcar33Leukemia, Myeloid, Acutephase1AndPhase2TerminatedDonor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell TransplantJul 19, 2023―
TelitaciceptSystemic Lupus ErythematosusPhase IIITerminatedA Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)Mar 23, 2022―
Vor33, MylotargLeukemia, Myeloid, Acute, Myelodysplastic Syndromesphase1AndPhase2TerminatedAllogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDSMar 25, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vor Biopharma, Inc. (VOR) have in its pipeline
Vor Biopharma VOR is currently developing the following drugs: Telitacicept, Vcar33, Vor33, Mylotarg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.